Tejnaksh Healthcare Ltd

Tejnaksh Healthcare, a microcap in the Hospital & Healthcare Services sector, has recently adjusted its evaluation amid flat financial performance for the September 2024 quarter. The company has faced a decline in operating profits over five years, while its stock shows some technical bullish momentum despite trading at a historical discount.

Tejnaksh Healthcare, a microcap in the Hospital & Healthcare Services sector, has recently experienced a change in evaluation based on financial metrics and market dynamics. The company faces liquidity challenges and a declining CAGR in operating profits, yet its stock shows positive technical trends despite underperforming against the BSE 500 index.

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, reported a flat performance in the second quarter of fiscal year 2024-2025. While operating profit and profit after tax were the highest in the last five quarters, cash and cash equivalents were the lowest in the last six periods. Investors should carefully evaluate these factors before investing in the company's stock.

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, has received a 'Sell' rating from MarketsMOJO due to weak long-term fundamental strength and a mildly bearish technical trend. The company has consistently underperformed against the benchmark index and its profits have only recently shown improvement. Despite attractive valuations, investors should carefully consider these factors before investing.

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, has received a 'Hold' rating from MarketsMOJO after reporting positive results in June 2024. The stock is currently in a mildly bullish range and has shown improvement from a mildly bearish trend. Despite a negative return in the past year, the company's profits have increased and it is trading at an attractive valuation. However, it has weak long-term fundamental strength and has underperformed the market.

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, received a 'Sell' rating from MarketsMOJO on October 4th, 2024 due to weak long-term fundamental strength and a -2.60% CAGR growth in operating profits over the last 5 years. The stock has also underperformed the BSE 500 index and has a low PEG ratio, but its majority shareholders are the promoters themselves.

Tejnaksh Healthcare, a microcap company in the hospital and healthcare services industry, received a 'Hold' rating from MarketsMOJO on October 1, 2024. The company reported positive results in June 2024, with a high debtors turnover ratio and attractive valuation. However, weak long-term fundamentals and underperformance in the market may be a concern for investors.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has reported flat performance for the quarter ending June 2024. However, there has been a slight improvement in the company's overall score and its Profit After Tax has increased to Rs 0.60 crore, the highest in the last five quarters. Debtors Turnover Ratio has also been the highest, indicating efficient debt management.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has hit a 52-week low on July 11, 2024, with a stock price of Rs. 21.4. The stock has underperformed the sector by -1.47% and is currently trading below its moving averages. In the past year, it has shown a negative performance of -36.28%, indicating its struggle to keep up with the market trend.

Tejnaksh Healthcare has reported a flat performance for the quarter ending March 2024, but has shown significant improvement in its overall score. The company's Profit After Tax for the half-yearly period is higher than the preceding 12 months, and its revenue has already surpassed the previous 12 months in just half a year. Despite a 'Strong Sell' call from MarketsMOJO, investors should conduct their own research before investing.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has recently hit a 52-week low and received a 'Strong Sell' call from MarketsMOJO. The stock has been consistently falling for the past two days and is trading below all its moving averages. In the past year, the stock has seen a decline of -35.47%, highlighting its struggles in the market.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has hit a 52-week low on April 3rd, 2024. With a 'Strong Sell' rating from MarketsMOJO and underperforming the sector by -2%, the stock has seen a downward trend and is currently trading below all its moving averages. Its one-year performance is significantly lower than the Sensex, indicating struggles in the market.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has hit a 52-week low on March 12, 2024. According to MarketsMOJO, the stock has been given a 'Strong Sell' rating and has underperformed the sector by -8.2%. The stock has shown high volatility and is currently trading below its moving averages, indicating a bearish trend. In the past year, it has declined by -41.71%, further supporting the 'Strong Sell' rating. Investors and experts are advised to closely monitor the stock's performance and make informed decisions based on their own research and risk appetite.

Tejnaksh Health has shown steady growth in revenue with a 2.5% QoQ and 12.3% YoY increase. The company's OPM has also improved to 8.5%, indicating efficient cost management. With a low debt to equity ratio of 0.06 and positive cash flow from operations, the company has a strong financial position. However, MarketsMOJO has given a 'Strong Sell' call, citing potential challenges in the healthcare industry and market conditions. Investors should carefully evaluate all factors before investing.

Tejnaksh Healthcare, a microcap company in the healthcare services industry, has hit a 52-week low on January 20, 2024, with a stock price of Rs. 25.6. The company's performance has consistently been lower than the market average, indicating potential challenges in the current market conditions. Investors are advised to carefully consider their options before investing in this stock.